Ariad's "Poison Pill" Plan Comes After Former Icahn Exec Buys Stake
Investors seem boyed by Ariad Pharmaceuticals’ decision Friday to adopt a plan designed to prevent takeovers, raising the company’s stock price 22 percent since the Friday morning announcement...
Related Articles
- New Baxter CEO Steps Down From EMC Board also published in Business News
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also categorized in BoardNews
- Why Should We Care About Corporate Interlocks? also categorized in BoardNews
- Hewlett-Packard Shakes Up Management, Raises Outlook also mentions Management
- Six Years Later, The Problem at HP is Still the Board also categorized in BoardNews
- Germany's Corporate Governance Problem also categorized in BoardNews
- 20 Taiwan Businesspeople To Watch -- James Kuo, Austin Liu and Andy Lu also categorized in BoardNews
- Why State Street is Giving Shareholders a Bigger Say over Its Board also published in Business News
- Ariad CEO to Retire Due to Pressure From Shareholders also written by Don Seiffert
- Verastem directors buy $475K of stock, company set for potential pivotal trials also written by Don Seiffert
Login to comment.